Recently, Freed-Pastor et al.22 have described that the mutant p53 is recruited at the promoters of sterol genes by SREBPs to upregulate the expression of the sterol biosynthesis enzymes in human breast cancer cells. Here, TP53 is linked to breast carcinoma.